A sweeping new review of ADHD treatments—drawing on more than 200 meta-analyses—cuts through years of mixed messaging and hype. To make sense of it all, researchers have launched an interactive, ...
Azurity Pharmaceuticals, Inc. announced that ARYNTA™ (lisdexamfetamine dimesylate) Oral Solution will be available mid-2026 for treating ADHD in adults and pediatric patients 6 years and older. Arynta ...
Penn researchers say this treatment strategy can cause fatigue, sedation and serious drug interactions like abnormal heart rhythms.
ADHD is a common condition impacting five per cent of the population in Ireland and around 60,000 children. In recent years, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results